May 24, 2010 - Utilizing the iso-osmolar agent Visipaque (iodixanol) could save hospitals $54,617 per 100 patients when ...
Contrast Media
Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues. This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.
May 19, 2010 – A new study shows a single photon emission computed tomography (SPECT) imaging agent can identified ...
When digital electronic devices are first released on the market, they are sold at a premium. Gradually, as their ...
Bayer Radiology’s Barbara Ruhland and Thom Kinst discuss how radiology departments can address the many different ...
The biggest challenge in applying best practices in radiology workflow is seeing the big picture. The entire imaging ...
February 28, 2010 - Patients expressed a statistically significant preference for the taste of iohexol over diatrozoate ...
February 17, 2010 — An agreement has been reached to further augment and diversify a manufacturer's supply of molybdenum ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
February 2, 2010 – When doctors added contrast agent gadolinium during magnetic resonance imaging (MRI) they improved ...
January 20, 2010 - The first FDA-cleared contrast imaging agent for use with a magnetic resonance angiography (MRA) ...
Robert G. Mitchell, senior manager, contrast imaging solutions, explains how Bracco Diagnostics' acquisition of E-Z-EM ...
A patient’s chance of recovery can be directly impacted when a diagnosis is missed or delayed. To get the right ...
November 18, 2009 - Pancreatic cancer remains one of the deadliest cancers, with a prognosis of just six months to live ...
November 10, 2009 – Covidien said yesterday it will voluntarily contraindicate the use of its Optimark gadoversetamide ...
October 28, 2009 - The imaging industry, especially the new molecular technologies, will drive personalized medicine, in ...
Product Indications and Use: CLARISCAN (gadoterate meglumine) is a gadolinium-based contrast agent indicated for ...
October 8, 2009 – Lantheus Medical Imaging Inc. said two oral presentations featuring gadofosveset trisodium, the first ...
October 5, 2009 – A new analysis reaffirms that Lexiscan (regadenoson) Injection, the first selective A2A adenosine ...
Aug 12, 2009 - The Peripheral and Central Nervous System Drugs advisory committee of the U.S. Food and Drug ...
August 3, 2009 - Cardinal Health today announced it has agreed to acquire the assets of privately held Biotech, an ...
July 30, 2009 - The iso-omolar contrast medium iodixanol does not yield lower rates of contrast-induced acute kidney ...
July 1, 2009 — High doses, gadolinium-based MRI contrast agents alone are not sufficient to cause nephrogenic systemic ...
June 13, 2009 - Lantheus will be the first company to be able to offer Technetium-99 (Tc99m) derived from LEU to the U.S ...
June 12, 2009 - NanoScan Imaging LLC today announced the publication of new data demonstrating the use of its ...
May 24, 2010 